Czajkowska, A.; Guzinska-Ustymowicz, K.; Pryczynicz, A.; Lebensztejn, D.; Daniluk, U.
Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis? J. Clin. Med. 2022, 11, 2655.
https://doi.org/10.3390/jcm11092655
AMA Style
Czajkowska A, Guzinska-Ustymowicz K, Pryczynicz A, Lebensztejn D, Daniluk U.
Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis? Journal of Clinical Medicine. 2022; 11(9):2655.
https://doi.org/10.3390/jcm11092655
Chicago/Turabian Style
Czajkowska, Aleksandra, Katarzyna Guzinska-Ustymowicz, Anna Pryczynicz, Dariusz Lebensztejn, and Urszula Daniluk.
2022. "Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?" Journal of Clinical Medicine 11, no. 9: 2655.
https://doi.org/10.3390/jcm11092655
APA Style
Czajkowska, A., Guzinska-Ustymowicz, K., Pryczynicz, A., Lebensztejn, D., & Daniluk, U.
(2022). Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis? Journal of Clinical Medicine, 11(9), 2655.
https://doi.org/10.3390/jcm11092655
